Showing 481 - 500 results of 796 for search '"regenerative medicine"', query time: 0.06s Refine Results
  1. 481
  2. 482
  3. 483
  4. 484

    Manufacturing of Human Umbilical Cord Mesenchymal Stromal Cells on Microcarriers in a Dynamic System for Clinical Use by Florian Petry, J. Robert Smith, Jasmin Leber, Denise Salzig, Peter Czermak, Mark L. Weiss

    Published 2016-01-01
    “…The great properties of human mesenchymal stromal cells (hMSCs) make these cells an important tool in regenerative medicine. Because of the limitations of hMSCs derived from the bone marrow during isolation and expansion, hMSCs derived from the umbilical cord stroma are a great alternative to overcome these issues. …”
    Get full text
    Article
  5. 485
  6. 486

    Biological Effects of Culture Substrates on Human Pluripotent Stem Cells by Yohei Hayashi, Miho Kusuda Furue

    Published 2016-01-01
    “…Understanding the role of culture substrates in hPSC self-renewal and differentiation enables us to control hPSC behavior precisely and to establish scalable or microfabricated culture technologies for regenerative medicine and drug development.…”
    Get full text
    Article
  7. 487
  8. 488

    Mesenchymal Stem Cells as Therapeutics Agents: Quality and Environmental Regulatory Aspects by Patricia Galvez-Martin, Roger Sabata, Josep Verges, José L. Zugaza, Adolfina Ruiz, Beatriz Clares

    Published 2016-01-01
    “…Mesenchymal stem cells (MSCs) are one of the main stem cells that have been used for advanced therapies and regenerative medicine. To carry out the translational clinical application of MSCs, their manufacturing and administration in human must be controlled; therefore they should be considered as medicine: stem cell-based medicinal products (SCMPs). …”
    Get full text
    Article
  9. 489

    Comparison of Immunological Characteristics of Mesenchymal Stem Cells from the Periodontal Ligament, Umbilical Cord, and Adipose Tissue by Jin-Hee Kim, Chris H. Jo, Hang-Rae Kim, Young-il Hwang

    Published 2018-01-01
    “…Mesenchymal stem cells (MSCs) are of therapeutic importance in the fields of regenerative medicine and immunological diseases. Accordingly, studies evaluating MSCs for clinical applications are increasing. …”
    Get full text
    Article
  10. 490
  11. 491
  12. 492
  13. 493

    Biomimetic peptide conjugates as emerging strategies for controlled release from protein-based materials by Juthatip Manissorn, Jaturong Promsuk, Kittikhun Wangkanont, Peerapat Thongnuek

    Published 2025-12-01
    “…This review focuses on the design and integration of biomimetic peptides into these biopolymer platforms to control the release of bioactive molecules, thereby enhancing their functionality for drug delivery, tissue engineering, and regenerative medicine. Elastin-like polypeptides (ELPs) and silk fibroin repeats, for example, demonstrate how engineered peptides can mimic natural protein domains to modulate material properties and drug release profiles. …”
    Get full text
    Article
  14. 494
  15. 495

    Polymeric Scaffolds in Tissue Engineering Application: A Review by Brahatheeswaran Dhandayuthapani, Yasuhiko Yoshida, Toru Maekawa, D. Sakthi Kumar

    Published 2011-01-01
    “…Current strategies of regenerative medicine are focused on the restoration of pathologically altered tissue architectures by transplantation of cells in combination with supportive scaffolds and biomolecules. …”
    Get full text
    Article
  16. 496
  17. 497
  18. 498

    Challenges and Controversies in Human Mesenchymal Stem Cell Therapy by Barbara Lukomska, Luiza Stanaszek, Ewa Zuba-Surma, Pawel Legosz, Sylwia Sarzynska, Katarzyna Drela

    Published 2019-01-01
    “…In this review, we intend to address some problems and critically discuss the complex nature of MSCs in the context of their effective and safe applications in regenerative medicine in different diseases including graft versus host disease (GvHD) and cardiac, neurological, and orthopedic disorders.…”
    Get full text
    Article
  19. 499

    Exploring Novel Non-Operative Treatments for Osteoarthritis: An Examination of Innovative Therapies by Piotr Robert Bakuła, Kamila Jałocha, Joanna Zygadło

    Published 2025-02-01
    “…Cutting-edge technologies such as RNA interference, CRISPR/Cas9, and advanced regenerative medicine are also explored for their potential to revolutionize OA management. …”
    Get full text
    Article
  20. 500